Clinical Trials
37 trialsNelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
PIERCE
AGO Research GmbH
Reiki-Brachy
University of Utah
DOVE
Yonsei University
DaVulvaRec
University of Aarhus
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
ANTARES
Instituto do Cancer do Estado de São Paulo
MITO VULVA-01
National Cancer Institute, Naples
Electrochemotherapy for Recurrent Vulvar Cancer
Institute of Oncology Ljubljana
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Rutgers, The State University of New Jersey
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Rutgers, The State University of New Jersey
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Sichuan Enray Pharmaceutical Sciences Company
NODE
Queensland Centre for Gynaecological Cancer
3D Printed Custom Applicators for HDR BT (DISCO)
Royal North Shore Hospital
SCANDARE
Institut Curie
STRIVE
British Columbia Cancer Agency
AKIR001
Karolinska University Hospital
Image-Guided Gynecologic Brachytherapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Dana-Farber Cancer Institute
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
Emory University
RELAY
Dana-Farber Cancer Institute
CYCLOPS
CNAO National Center of Oncological Hadrontherapy
Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
Yuhan Corporation
START-001
Marengo Therapeutics, Inc.
ASQ-GYO
Barbara Ann Karmanos Cancer Institute
Vulvar-AIN
Sunnybrook Health Sciences Centre
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Northwestern University
AK104 for Recurrent or Metastatic Vulvar Cancer
Akeso
AMethysT
Assistance Publique - Hôpitaux de Paris
A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
Zhejiang Cancer Hospital
HPV-VIM
Baylor College of Medicine
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
The Affiliated Hospital of Qingdao University
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Shanghai Bovax Biotechnology Co., Ltd.
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Shanghai Bovax Biotechnology Co., Ltd.
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
HRYZ Biotech Co.
GROINSS-VIII
University Medical Center Groningen
Elechtra
IRCCS Azienda Ospedaliero-Universitaria di Bologna